| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-11 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |